Posts Tagged ‘Risperdal lawsuit’
Class Action Lawyer Network Risperdal Lawyers Filing Lawsuits For Enlarged Breasts (Gynecomastia) in Young Men From Risperdal
A number of lawsuits have been filed alleging the use of Risperdal cauded enlarged breast tissue in young men. Johnson & Johnson has already settled the first of over 100 Risperdal gynecomastia lawsuits. If your son was a victim of Risperdal and it caused severe emotional harm and medical, surgical intervention call and speak to one of our Risperdal lawyers today.
Risperdal Has Been l Linked to Gynecomastia
Risperdal is an antipsychotic medication manufactured by Johnson & Johnson used to treat psychiatric disorders. Young boys on this medication have severe psychological problems. Using Risperdal may lead to breast growth in men, or gynecomastia. The result is severe emotional and medical problems including:
Nipple discharge in one or both breasts
The need for surgery for breast reduction
Psychological effects including suicidal ideation
If Your Son Has Been A Victim The Choice Is Clear
If you or a loved one took Risperdal and suffered from gynecomastia or other potential side effects you must consider filing a lawsuit against the manufacturer. Call and speak to one of our Risperdal attorneys
Johnson will be paying $2.5 billion in the ASR and Pinnacle . hip implant settlements
NEW YORK (Reuters) – A unit of Johnson & Johnson has agreed to pay an estimated $2.5 billion to settle thousands of lawsuits from individuals allegedly injured by the company's artificial hip implants, the company announced Tuesday.
The settlement, announced during a hearing in federal court in Ohio on Tuesday, would compensate an estimated 8,000 patients who underwent surgery to replace their hip implants, according to a statement from Johnson & Johnson unit Depuy Orthopaedics Inc and DePuy Hip Replacement lawyers for the victims.
al The company was defending more than 12,000 lawsuits in U.S. state and federal court over injuries allegedly caused by its metal-on-metal ASR hip-replacement systems, according to a regulatory filing.
Depuy recalled the ASR hip system in 2010, after data suggested that it failed at a higher-than-expected rate. At the time, the company had sold about 93,000 systems worldwide.
Metal hip implant systems like Depuy's ASR hips were designed to be more durable, replacing a traditional metal-on-plastic ball-and-socket design. Instead, some patients who received the ASR hips reported experiencing pain, swelling, joint dislocation and sometimes damage to the central nervous system, thyroid and heart.
The settlement would compensate plaintiffs who have undergone surgery to replace their hips as of August 31, 2013, the company said Tuesday. The company estimated that 8,000 plaintiffs would be eligible.
There is no cap on the amount of individual claims, according to Peter Flowers, one of the lead lawyers for the plaintiffs. Eligible U.S. plaintiffs can seek compensation for costs associated with their revision surgery, as well as payments of qualified liens by healthcare providers associated with the surgery, Flowers said.
You Can Opt To Continue The Lawsuit and Not Accept The Offer
Plaintiffs who opt not to participate in the program, or those who have not undergone revision surgery to replace their implants, will continue to litigate.
The company said it will continue to defend itself in the remaining lawsuits not resolved by the agreement. It also said that it expected the cost of the settlement program to be covered by reserves it had previously set aside, and did not expect to record an additional charge in connection with the agreement.
"The U.S. settlement program provides compensation for eligible patients without the delay and uncertainty of protracted litigation," said Andrew Ekdahl, president of Depuy Synthes Joint Reconstruction, in a statement.
The settlement is not subject to court approval, according to a Johnson & Johnson spokeswoman, Lorie Gawreluk.
Johnson and Johnson Faces Risperdal Lawsuits
The announcement comes just weeks after Johnson & Johnson announced it would pay $2.2 billion to resolve civil and criminal probes into its marketing of several medications, including the anti-psychotic drug Risperdal.
Johnson and Johnson Faces Vaginal Mesh Implant Lawsuit
The Ethicon subsidiary is also a defendant in more than 23,000 lawsuits over vaginal mesh implants, according to a quarterly filing with the U.S. Securities and Exchange Commission.
If you or a loved on has a failed DePuy Pinnacle or ASR and has needed revision surgery call us for a hip replacement lawyer. We are alo accepting Risperdal and vaginal mesh lawsuits.
Risperdal Lawyers Filing Gynecomastia Lawsuits
If you or a loved one was prescribed Risperdal as a teenage boy and now have enlarged breasts, developed female type breasts and /or been diagnosed with Gynecomastia, contact Class Action Lawyer Network Risperdal Injury Lawyers today to discuss your options in a Risperdal lawsuit.
Our Resperdal lawyers are reviewing cases for young boys diagnosed with gynecomastia or male breasts after using Risperdal. Problems may result in:
- Breast Growth Among Boys
- Puffy Nipples or Enlarged Nipples
- Galactorrhea (production of milk from breasts)
- Painful Breasts or Nipple Discharge
- Mastectomy or Gynecomastia Surgery to Remove Male Breasts
- Gynecomastia (growth of male breasts, which may be painful or tender)
If your son has been diagnosed with Gynacomastia call our Resperdal helpline and speak to our trained medical social worker today.
Rispedral Side Effects In Male Children
Risperdal (risperidone) is an antipsychotic manufactured by Johnson & Johnson. It was originally approved by the FDA for use for adults with schizophrenia. Risperdal has also been widely used by children for bi-polar disorders, autism, irritability, aggression and behavior disorders.
Speak To A Risperdal Lawyer
The Riserdal lawyers are reviewing cases for Risperdal breast growth among boys.
Children Are Being Injured By Risperdal
Lawsuits are being filed for abnormal development of large mammary glands among boys and adolescents, resulting in breast development. Surgery has been necessary to remove the breasts caused by the Risperdal gynecomastia. This has caused emotional trauma for boys and young adult males and some incidents of suicide. Parents throughout the United States are pursuing a Rispedal lawsuit on behalf of kchildren who developed breasts on Risperdal.
Lawsuits allege that Johnson & Johnson failed to adequately research the effects of their medication or warn about the connection between Risperdal and breast growth.
Risperdal Lawsuit Update
Although Resperdal is not currently an MDL, settlements for Risperdal breast growth have been reached by Johnson & Johnson in lawsuits bellwether trials where a number of cases are presented to juries to test the potential settlements and outcomes. Do not delay. Call no to discuss a Resperdal lawsuit.